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Abstract 
Short communication on t(1;9)(p13;p12) 
PAX5/HIPK1, with data on clinics, and the genes 
implicated. 
Clinics and pathology 
Disease 
B-cell acute lymphoblastic leukemia (B-ALL) 
Epidemiology 
Only one case to date, a 3-year old boy with a 
CD10+ ALL (Nebral et al., 2009). 
Prognosis 
The patient was noted at an intermediate risk, and 
was in complete remission 6 months after 
diagnosis. 
Genes involved and 
proteins 
HIPK1 
Location 
1p13.2 
Protein 
1210 amino acids (aa). From N-term to C-term, 
contains a protein kinase domain (aa 190-518), a 
nucleotide binding motif (aa 196-204), a domain 
interacting with DAB2IP (AIP1, or AF9q34, 
9q33.2) (aa 518-889), a nuclear localization signal 
(aa 844-847), a region interacting with TP53 (aa 
885-1093), a nuclear speckle retention signal (aa 
887-992), (corresponding to aa 860-967 in HIPK2), 
a PEST domain (enriched in proline (P), glutamate 
(E), serine (S), and threonine (T), expedite the 
degradation of proteins) (aa 892-972), SUMO 
interaction motifs, required for nuclear localization 
and kinase activity (aa 902-926), a domain 
interacting with DAB2IP/MAP3K5 (aa 973-1209), 
a histidine-rich region (aa 1086-1154), and a 
tyrosine-rich region (aa 1175-1209) (YH region). 
The lysine residues at the sumoylation motifs are 
the following: K25, K317, K440, K556, and K1202 
(Kim et al., 1998; Li et al., 2005; Swiss-Prot). 
First identified as a nuclear serine/threonine kinase. 
Homeodomain-interacting protein kinase. HIPK1 
positively or negatively modulate signaling 
pathways controlling cell proliferation and/or 
apoptosis (review in Rinaldo et al., 2008). HIPK1 
and HIPK2 act cooperatively as corepressors in the 
transcriptional activation of angiogenic genes, 
including MMP10 (11q22.2) and VEGFA (6p21.1), 
that are critical for the early stage of vascular 
development (Shang et al., 2013).  
HIPK1 regulates the p53 signaling pathway. 
PARK7 (also called DJ-1, 1p36.23), a protein also 
linked to the p53 signaling pathway, is able to 
induce HIPK1 degradation.  
HIPK1 directly phophorylates TP53 on its serine-
15. Serine 15 phosphorylation induces a rise in 
CDKN1A (p21, 6p21.2) expression and cell cycle 
arrest (Rey et al., 2013).  
HIPK1 phosphorylates DAXX (6p21.32), a protein 
which interacts with PML (15q24.1), the organizer 
of nuclear bodies (Ecsedy et al., 2003), and which 
relocalizes from the nucleus to the cytoplasm in 
response to stress. During glucose deprivation, a 
pathway involving MAP3K5 (also called ASK1, 
6q23.3), -> MAP2K4 (SEK1, 17p12) -> MAPK8 
(JNK1, 10q11.22) -> HIPK1 is activated, and 
DAXX is relocated in the cytoplasm (Song and 
Lee, 2003).  
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t(1;9)(p13;p13) PAX5/HIPK1 fusion protein. 
 
TNF (TNF-alpha, 6p21.33) induces desumoylation 
and cytoplasm translocation of HIPK1 leading to 
apoptosis (Li et al., 2005). HIPK1 and HIPK2 bind 
HOX genes homeodomains and regulate their 
expression, as well as PAX1 (20p11.22) and PAX3 
(2q36.1) transcription (Isono et al., 2006). HIPK1 
and HIPK2 phosphorylates EP300 (22q13.2) and 
RUNX1 (21q22.12) during embryonic 
development, and Hipk1/Hipk2-deficient mice 
show defective definitive hematopoiesis (Aikawa et 
al., 2006). HIPK1 phosphorylates MYB (6q23.3), a 
transcriptional activator essential for the 
establishment of haemopoiesis, and causes 
repression of MYB activation (Matre et al., 2009). 
HIPK1 interacts with DVL1 (1p36.33) and TCF3 
(E2A, 19p13.3) and regulates Wnt/b-catenin target 
genes during early embryonic development (Louie 
et al., 2009). HIPK1 is highly overexpressed in 
colorectal carcinomas compared with healthy 
mucosa. The highest peak of HIPK1 expression 
occurred at early stages and decreased in latter 
stages. HIPK1 appeared to be induced as a defense 
mechanism to fight against intern deregulations and 
stressful conditions, rather than produced by the 
cancer cells as an indispensable factor for tumor 
evolution (Rey et al., 2013). HIPK1 is expressed 
only in invasive breast cancer cells with three 
different subcellular localization, associated with 
different tumor histopathologic characteristics (Park 
et al., 2012). 
PAX5 
Location 
9p13.2 
Protein 
391 amino acids; from N-term to C-term, PAX5 
contains: a paired domain (aa: 16-142); an 
octapeptide (aa: 179-186); a partial homeodomain 
(aa: 228-254); a transactivation domain (aa: 304-
359); and an inhibitory domain (aa: 359-391). 
Lineage-specific transcription factor; recognizes the 
concensus recognition sequence 
GNCCANTGAAGCGTGAC, where N is any 
nucleotide.  
Involved in B-cell differentiation. Entry of common 
lymphoid progenitors into the B cell lineage 
depends on E2A, EBF1, and PAX5; activates B-cell 
specific genes and repress genes involved in other 
lineage commitments. Activates the surface cell 
receptor CD19 and repress FLT3. Pax5 physically 
interacts with the RAG1/RAG2 complex, and 
removes the inhibitory signal of the lysine-9-
methylated histone H3, and induces V-to-DJ 
rearrangements. Genes repressed by PAX5 
expression in early B cells are restored in their 
function in mature B cells and plasma cells, and 
PAX5 repressed (Fuxa et al., 2004; Johnson et al., 
2004; Zhang et al., 2006; Cobaleda et al., 2007; 
Medvedovic et al., 2011). 
Result of the chromosomal 
anomaly 
Hybrid gene 
Description 
Fusion of PAX5 exon 5 to HIPK1 exon 9. 
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Fusion protein 
Description 
751 amino acids. The predicted fusion protein 
contains the DNA binding paired domain of PAX5 
and the nuclear localization signal, the region 
interacting with TP53, the nuclear speckle retention 
signal, the PEST domain, the SUMO interaction 
motifs, the domain interacting with 
DAB2IP/MAP3K5, and theYH region from HIPK1. 
References 
Kim YH, Choi CY, Lee SJ, Conti MA, Kim Y. 
Homeodomain-interacting protein kinases, a novel family 
of co-repressors for homeodomain transcription factors. J 
Biol Chem. 1998 Oct 2;273(40):25875-9 
Ecsedy JA, Michaelson JS, Leder P. Homeodomain-
interacting protein kinase 1 modulates Daxx localization, 
phosphorylation, and transcriptional activity. Mol Cell Biol. 
2003 Feb;23(3):950-60 
Song JJ, Lee YJ. Role of the ASK1-SEK1-JNK1-HIPK1 
signal in Daxx trafficking and ASK1 oligomerization. J Biol 
Chem. 2003 Nov 21;278(47):47245-52 
Fuxa M, Skok J, Souabni A, Salvagiotto G, Roldan E, 
Busslinger M. Pax5 induces V-to-DJ rearrangements and 
locus contraction of the immunoglobulin heavy-chain gene. 
Genes Dev. 2004 Feb 15;18(4):411-22 
Johnson K, Pflugh DL, Yu D, Hesslein DG, Lin KI, Bothwell 
AL, Thomas-Tikhonenko A, Schatz DG, Calame K. B cell-
specific loss of histone 3 lysine 9 methylation in the V(H) 
locus depends on Pax5. Nat Immunol. 2004 Aug;5(8):853-
61 
Li X, Zhang R, Luo D, Park SJ, Wang Q, Kim Y, Min W. 
Tumor necrosis factor alpha-induced desumoylation and 
cytoplasmic translocation of homeodomain-interacting 
protein kinase 1 are critical for apoptosis signal-regulating 
kinase 1-JNK/p38 activation. J Biol Chem. 2005 Apr 
15;280(15):15061-70 
Aikawa Y, Nguyen LA, Isono K, Takakura N, Tagata Y, 
Schmitz ML, Koseki H, Kitabayashi I. Roles of HIPK1 and 
HIPK2 in AML1- and p300-dependent transcription, 
hematopoiesis and blood vessel formation. EMBO J. 2006 
Sep 6;25(17):3955-65 
Isono K, Nemoto K, Li Y, Takada Y, Suzuki R, Katsuki M, 
Nakagawara A, Koseki H. Overlapping roles for  
homeodomain-interacting protein kinases hipk1 and hipk2 
in the mediation of cell growth in response to 
morphogenetic and genotoxic signals. Mol Cell Biol. 2006 
Apr;26(7):2758-71 
Zhang Z, Espinoza CR, Yu Z, Stephan R, He T, Williams 
GS, Burrows PD, Hagman J, Feeney AJ, Cooper MD. 
Transcription factor Pax5 (BSAP) transactivates the RAG-
mediated V(H)-to-DJ(H) rearrangement of immunoglobulin 
genes. Nat Immunol. 2006 Jun;7(6):616-24 
Cobaleda C, Schebesta A, Delogu A, Busslinger M. Pax5: 
the guardian of B cell identity and function. Nat Immunol. 
2007 May;8(5):463-70 
Rinaldo C, Siepi F, Prodosmo A, Soddu S. HIPKs: Jack of 
all trades in basic nuclear activities. Biochim Biophys Acta. 
2008 Nov;1783(11):2124-9 
Louie SH, Yang XY, Conrad WH, Muster J, Angers S, 
Moon RT, Cheyette BN. Modulation of the beta-catenin 
signaling pathway by the dishevelled-associated protein 
Hipk1. PLoS One. 2009;4(2):e4310 
Matre V, Nordgård O, Alm-Kristiansen AH, Ledsaak M, 
Gabrielsen OS. HIPK1 interacts with c-Myb and modulates 
its activity through phosphorylation. Biochem Biophys Res 
Commun. 2009 Oct 9;388(1):150-4 
Nebral K, Denk D, Attarbaschi A, König M, Mann G, Haas 
OA, Strehl S. Incidence and diversity of PAX5 fusion 
genes in childhood acute lymphoblastic leukemia. 
Leukemia. 2009 Jan;23(1):134-43 
Medvedovic J, Ebert A, Tagoh H, Busslinger M. Pax5: a 
master regulator of B cell development and 
leukemogenesis. Adv Immunol. 2011;111:179-206 
Park BW, Park S, Koo JS, Kim SI, Park JM, Cho JH, Park 
HS. Homeodomain-interacting protein kinase 1 (HIPK1) 
expression in breast cancer tissues. Jpn J Clin Oncol. 
2012 Dec;42(12):1138-45 
Rey C, Soubeyran I, Mahouche I, Pedeboscq S, Bessede 
A, Ichas F, De Giorgi F, Lartigue L. HIPK1 drives p53 
activation to limit colorectal cancer cell growth. Cell Cycle. 
2013 Jun 15;12(12):1879-91 
Shang Y, Doan CN, Arnold TD, Lee S, Tang AA, Reichardt 
LF, Huang EJ. Transcriptional corepressors HIPK1 and 
HIPK2 control angiogenesis via TGF-β-TAK1-dependent 
mechanism. PLoS Biol. 2013;11(4):e1001527 
This article should be referenced as such: 
Huret JL. t(1;9)(p13;p12) PAX5/HIPK1. Atlas Genet 
Cytogenet Oncol Haematol. 2014; 18(9):685-687. 
